Radius Health, Inc. is a biopharmaceutical company, focused on the development of endocrine therapeutics in the areas of osteoporosis and oncology. In April 2017, the FDA approved Tymlos (abaloparatide -SC) injection for the treatment of postmenopausal women with high risk osteoporosis for fracture - defined as history of osteoporotic fracture - multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy.
Address Details
Address: 22 BOSTON WHARF ROAD 7TH FLOOR
City: BOSTON
State: MA
Country: USA
Zip Code: 02210
Contact Details
617-551-4000
This weeks newsletter: 🚀 Retail Access to SpaceX, BlackBerry’s Big Moves, Trends to Watch 📈